Market DriversSeveral key factors are contributing to the rapid expansion of the botulinum toxin market: Growing Demand for ...

Botulinum toxin, a neurotoxin produced by the gram-positive anaerobic bacterium Clostridium botulinum, is available in Type A and Type B forms, and extensively used in therapeutic and aesthetic ...

Therapeutic Botox, the kind used medically, is now being used for a variety of medical conditions, including migraines.

Letybo, an acetylcholine release inhibitor and a neuromuscular blocking agent, was approved in March 2024 based on data from three phase 3 trials.